Search Results

Site Search

Insights - Insights

Skip to Content MayoACCESS MayoLINK...

Autoimmune testing education - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...

Top Gun Phlebotomy: Pseudohyperkalemia - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., describes how pseudohyperkalemia has many causes, from collection techniques, processing, and even transport. This presentation focuses on the various preanalytic and analytic causes of...

MCL Molecular Genetics Neurology Patient Information MC1235235

MCL Molecular Genetics Neurology Patient Information Complete print Molecular Genetics Neurology Patient Information Reset Form Instructions accurate interpretation reporting genetic results

hivtestingalgorithmfourthgenerationscreeningassayincludingfollowupofreactivehivrapidserologictestres.pdf

HIV-1 Ab Negative HIV-2 Ab Negative HIV-1 RNA Negative HIV-2 RNA Negative HIV-1 Ab Negative HIV-2 Ab Indeterminate HIV-1 RNA Negative HIV-2 RNA Positive HIV-1 Ab Indeterminate HIV-2 Ab Indeterminate HIV-1 RNA Positive HIV-2 RNA...

Hereditary - Insights

Learn about our hereditary cancer test offerings, including single-gene assays that evaluate specific genes already identified in a parent.

Patient spotlight - Insights

Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...

Bile acid malabsorption - Insights

Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...

Hereditary - Insights

Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.

MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732

MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular

https://news.mayocliniclabs.com/file-activity-metrics-user-guide/

Activity Metrics User’s Guide Release 1.21 Page 2 9/26/24 Activity Metrics User’s Guide TABLE OF CONTENTS Introduction...

US: South - Insights

Mayo Clinic Laboratories' algorithmic approach to vector-borne disease testing supports the selection of the right test for the right region. Our full suite of vector-borne disease tests includes expert-developed assays for the most...

FDA Regulation of Laboratory Developed Tests - Insights

PACE/State of FL - A brief history of the FDA’s interest in LDTs and detailing new requirements.

Mayo Clinic Laboratories and KYAN Technologies enter a collaboration to expand patients' access to cancer testing - Insights

Mayo Clinic Laboratories and KYAN Technologies announced a collaboration to validate and provide the KYAN test, Optim.AI™, across the United States.

Precision medicine for obesity program - Insights

PACE/State of CA/State of FL - In this month’s “Virtual Lecture,” Andres Acosta, M.D., Ph.D., discusses how individualized medicine can play a role in obesity.

Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights

Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...

People Archives - Page 3 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Discontinuation of Herpes Simplex Virus (HSV) IgM Testing - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of...

Dengue Virus: A Diagnostic Testing Update - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide....

Therapeutics events - Insights

TherapeuticS Creating the new standard of therapeutic management, together Mayo Clinic Laboratories’ evidence-based toxicology and pharmacogenomic testing

The 10 Types of Attendees You May Find at a Conference - Insights

Heidi Zunker, Education Program Manager, and Melissa Peterson, Education Specialist, at Mayo Medical Laboratories, discuss the 10 types of attendees you may find at a conference.

Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.

Pancreatic disease - Insights

Learn more about how Mayo Clinic Laboratories’ genetic testing for pancreatic disease can provide a clearer understanding of a patient’s condition.

Anti-hypertensive drug monitoring - Insights

Learn how Mayo Clinic Laboratories’ anti-hypertensive drug panel can assist physicians in understanding the reasons for resistant hypertension in patients.

Neuro-oncology - Insights

Learn how our pediatric neuro-oncology testing includes both comprehensive MayoComplete next-generation sequencing and chromosomal microarray.

Mucopolysaccharidosis - Insights

Learn more about how Mayo Clinic Laboratories’ testing for mucopolysaccharidosis can assist with diagnosis and disease management.

Genetics events - Insights

For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose. To provide meaningful answers, our...

Sarcoma Informative Cases - Insights

Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue.  With numerous subtypes of sarcoma that can

Pathways Case Studies: March 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cardiovascular...

Yuma Regional Medical Center: Changing perceptions and powering growth - Insights

Looking to elevate laboratory operations, Yuma Regional’s hospital directors established a leadership model that pairs medical and administrative leaders, resulting in a changed perception of the laboratory’s ability to drive profitability...

MCLRequest for Supplies MC0748

MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date

Elevating accuracy of Alzheimer's testing - Insights

Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.

Managing off-site phlebotomy: Considerations, coordination, and convenience - Insights

As the phlebotomist ventures farther from the hospital or formal outpatient setting, there are many new facets to consider. Remote phlebotomy is a patient-focused activity and can be a successful attribute for an outreach program when...

Gadolinium Accumulation in Brain Tissue following Contrast-Enhanced MRI Has Not Been Shown to Have Harmful Side Effects - Insights

Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...

Testing Archives - Page 8 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Therapeutics - Insights

Developed through evidence-driven clinical innovation and designed to deliver clarity on drug and alcohol use, our testing delivers results that advance understanding and improve outcomes.

Rheumatology - Insights

Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...

Own your lab - Insights

It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...

Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.

Lyme Disease, Part 2: Borrelia mayonii-A New Cause of Lyme Disease in Upper Midwest - Insights

In this “Hot Topic,” Bobbi Pritt, M.D., discusses how Lyme disease is the most common vector-borne illness in the United States and Europe and caused primarily by Borrelia burgdorferi in the United States, while B burgdorferi, B afzelii,...

Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.

PD-L1 Testing by Immunohistochemistry - Insights

In this month's "Hot Topic," Anja Roden, M.D., discusses the role of PD-L1 interaction in the immune system, challenges of PD-L1 testing, and current PD-L1 companion testing in various tumor types.

Alzheimer's Disease CSF Biomarkers - Insights

In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.

Therapeutics - Insights

Mayo Clinic Laboratories offers the industry’s most comprehensive therapeutics test menu. Developed by experts to align with governmental and professional recommendations, our assays combine cutting-edge methodologies with precision...

Chromogenic Factor VIII and IX Assays: Impact on Diagnosis and Management of Hemophilia - Insights

In this month’s “Hot Topic,” Rajiv Pruthi, M.B.B.S., will discuss different types of hemophilia along with their pathologic basis. He will also cover various types of factor assays such as one stage and chromogenic factor assays for...

Inborn errors of metabolism - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.

A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights

Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...

Mayo Clinic Labs @Work: Rehab Elkadri - Insights

Rehab Elkadri joined Mayo Clinic Laboratories in December 2021, relocating from the United Kingdom to the United Arab Emirates. As an international clinical specialty liaison in the Neurology division for the Middle East and North Africa...

MCL @Work: Becca Johnson - Insights

Becca Johnson, a dedicated project manager, joined Mayo Clinic in 2014, driven by a desire to contribute to an organization making a global impact. With BioPharma Diagnostics, Becca oversees large projects, ensuring efficient sample...

People Archives - Insights

Skip to Content MayoACCESS MayoLINK...